Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 020533

Expand all

NAROPIN (ROPIVACAINE HYDROCHLORIDE)
20MG/10ML (2MG/ML) Marketing Status: Prescription

Active Ingredient: ROPIVACAINE HYDROCHLORIDE
Proprietary Name: NAROPIN
Dosage Form; Route of Administration: SOLUTION; INJECTION
Strength: 20MG/10ML (2MG/ML)
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AP
Application Number: N020533
Product Number: 001
Approval Date: May 1, 1998
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status:  Prescription
Patent and Exclusivity Information

NAROPIN (ROPIVACAINE HYDROCHLORIDE)
40MG/20ML (2MG/ML) Marketing Status: Prescription

Active Ingredient: ROPIVACAINE HYDROCHLORIDE
Proprietary Name: NAROPIN
Dosage Form; Route of Administration: SOLUTION; INJECTION
Strength: 40MG/20ML (2MG/ML)
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AP
Application Number: N020533
Product Number: 002
Approval Date: Sep 24, 1996
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status:  Prescription
Patent and Exclusivity Information

NAROPIN (ROPIVACAINE HYDROCHLORIDE)
100MG/20ML (5MG/ML) Marketing Status: Prescription

Active Ingredient: ROPIVACAINE HYDROCHLORIDE
Proprietary Name: NAROPIN
Dosage Form; Route of Administration: SOLUTION; INJECTION
Strength: 100MG/20ML (5MG/ML)
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AP
Application Number: N020533
Product Number: 003
Approval Date: May 1, 1998
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status:  Prescription
Patent and Exclusivity Information

NAROPIN (ROPIVACAINE HYDROCHLORIDE)
100MG/10ML (10MG/ML) Marketing Status: Prescription

Active Ingredient: ROPIVACAINE HYDROCHLORIDE
Proprietary Name: NAROPIN
Dosage Form; Route of Administration: SOLUTION; INJECTION
Strength: 100MG/10ML (10MG/ML)
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AP
Application Number: N020533
Product Number: 005
Approval Date: Sep 24, 1996
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status:  Prescription
Patent and Exclusivity Information

NAROPIN (ROPIVACAINE HYDROCHLORIDE)
150MG/20ML (7.5MG/ML) Marketing Status: Prescription

Active Ingredient: ROPIVACAINE HYDROCHLORIDE
Proprietary Name: NAROPIN
Dosage Form; Route of Administration: SOLUTION; INJECTION
Strength: 150MG/20ML (7.5MG/ML)
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AP
Application Number: N020533
Product Number: 004
Approval Date: Sep 24, 1996
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status:  Prescription
Patent and Exclusivity Information

NAROPIN (ROPIVACAINE HYDROCHLORIDE)
150MG/30ML (5MG/ML) Marketing Status: Prescription

Active Ingredient: ROPIVACAINE HYDROCHLORIDE
Proprietary Name: NAROPIN
Dosage Form; Route of Administration: SOLUTION; INJECTION
Strength: 150MG/30ML (5MG/ML)
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AP
Application Number: N020533
Product Number: 008
Approval Date: Sep 24, 1996
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status:  Prescription
Patent and Exclusivity Information

NAROPIN (ROPIVACAINE HYDROCHLORIDE)
200MG/100ML (2MG/ML) Marketing Status: Prescription

Active Ingredient: ROPIVACAINE HYDROCHLORIDE
Proprietary Name: NAROPIN
Dosage Form; Route of Administration: SOLUTION; INJECTION
Strength: 200MG/100ML (2MG/ML)
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AP
Application Number: N020533
Product Number: 006
Approval Date: Sep 24, 1996
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status:  Prescription
Patent and Exclusivity Information

NAROPIN (ROPIVACAINE HYDROCHLORIDE)
200MG/20ML (10MG/ML) Marketing Status: Prescription

Active Ingredient: ROPIVACAINE HYDROCHLORIDE
Proprietary Name: NAROPIN
Dosage Form; Route of Administration: SOLUTION; INJECTION
Strength: 200MG/20ML (10MG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N020533
Product Number: 011
Approval Date: Sep 24, 1996
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status:  Prescription
Patent and Exclusivity Information

NAROPIN (ROPIVACAINE HYDROCHLORIDE)
400MG/200ML (2MG/ML) Marketing Status: Prescription

Active Ingredient: ROPIVACAINE HYDROCHLORIDE
Proprietary Name: NAROPIN
Dosage Form; Route of Administration: SOLUTION; INJECTION
Strength: 400MG/200ML (2MG/ML)
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N020533
Product Number: 007
Approval Date: Sep 24, 1996
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status:  Prescription
Patent and Exclusivity Information

NAROPIN (ROPIVACAINE HYDROCHLORIDE)
500MG/100ML (5MG/ML) Marketing Status: Prescription

Active Ingredient: ROPIVACAINE HYDROCHLORIDE
Proprietary Name: NAROPIN
Dosage Form; Route of Administration: SOLUTION; INJECTION
Strength: 500MG/100ML (5MG/ML)
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N020533
Product Number: 009
Approval Date: Jan 4, 2011
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status:  Prescription
Patent and Exclusivity Information

NAROPIN (ROPIVACAINE HYDROCHLORIDE)
1GM/200ML (5MG/ML) Marketing Status: Prescription

Active Ingredient: ROPIVACAINE HYDROCHLORIDE
Proprietary Name: NAROPIN
Dosage Form; Route of Administration: SOLUTION; INJECTION
Strength: 1GM/200ML (5MG/ML)
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N020533
Product Number: 010
Approval Date: Jan 4, 2011
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status:  Prescription
Patent and Exclusivity Information

NAROPIN (ROPIVACAINE HYDROCHLORIDE)
50MG/10ML (5MG/ML) Marketing Status: Discontinued

Active Ingredient: ROPIVACAINE HYDROCHLORIDE
Proprietary Name: NAROPIN
Dosage Form; Route of Administration: SOLUTION; INJECTION
Strength: 50MG/10ML (5MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020533
Product Number: 013
Approval Date: May 1, 1998
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status:  Discontinued
Patent and Exclusivity Information

NAROPIN (ROPIVACAINE HYDROCHLORIDE)
75MG/10ML (7.5MG/ML) Marketing Status: Discontinued

Active Ingredient: ROPIVACAINE HYDROCHLORIDE
Proprietary Name: NAROPIN
Dosage Form; Route of Administration: SOLUTION; INJECTION
Strength: 75MG/10ML (7.5MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020533
Product Number: 012
Approval Date: Sep 24, 1996
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status:  Discontinued
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English